Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 7, 2016; 22(25): 5769-5779
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5769
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5769
Figure 2 Urotensin II inhibits insulin receptor-mediated signal transduction in HepG2 cells.
HepG2 cells were exposed to 100 nmol/L urotensin II (UII) for 24 h prior to stimulation with insulin (100 nmol/L, 30 min), and total cell lysates were then subjected to Western blot analysis. UII impaired IRS-1 and Glut 2 protein levels and reduced phosphorylation of IRS-1, Akt, and GSK-3β (A-C). Data from at least three independent experiments are presented as the mean ± SD. bP < 0.01, dP < 0.001 vs control group; aP < 0.05, fP < 0.01, hP < 0.001 vs insulin treatment alone.
- Citation: Li YY, Shi ZM, Yu XY, Feng P, Wang XJ. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells. World J Gastroenterol 2016; 22(25): 5769-5779
- URL: https://www.wjgnet.com/1007-9327/full/v22/i25/5769.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i25.5769